drugset / Trial / NCT07655518

A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants

NCT07655518 ↗

Phase 1 Recruiting 12 enrolled Bristol-Myers Squibb
NaSequentialOpen-labelTreatment

Summary

The purpose of this study is to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants

Timeline

Start
2026-06-25
Primary completion
2026-12-27
Completion
2026-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986521 Unknown — Oral

Indications

No indication recorded.